Author

W A Christopherson

Observed names: W. Christopherson, WA Christopherson

Institutions: Mayo Clinic, Precision Therapeutics (United States), UPMC Health System, Mayo Clinic in Florida, The University of Texas Southwestern Medical Center

Observed institutions: Mayo Clinic, Precision Therapeutics (United States), UPMC Health System, Mayo Clinic in Florida, The University of Texas Southwestern Medical Center

OpenAlex ID: A5088310839

Placenta previa percreta involving the urinary bladder: a report of two cases and review of the literature.

1991 · F V Price, E Resnik, et al. · PubMed · 90

Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

1987 · R E Slayton, J A Blessing, et al. · PubMed · 29

The influence of pretreatment celiotomy and para-aortic lymphadenectomy on the management of advanced stage squamous cell carcinoma of the cervix.

1987 · W A Christopherson, H J Buchsbaum · PubMed · 3

Responsiveness of human carcinoma cells of gynecologic origin to 1,25-dihydroxycholecalciferol

1987 · WA Christopherson, JC Porter, et al. · International Journal of Gynecology & Obstetrics · 1

Ex vivo chemoresponse assay of ovarian cancers predicts clinical outcome

2004 · H. Gallion, W. Christopherson, et al. · Journal of Clinical Oncology

Disseminated granulomatous disease (BCGosis) following chemoimmunotherapy for ovarian carcinoma

1989 · MB Kelleher, WA Christopherson, et al. · International Journal of Gynecology & Obstetrics

Works count: 6

Citation count: 123

H-index: 3

I10-index: 2